Developed in collaboration with researchers from Emory University and The Children’s Hospital of Philadelphia, the SureSelect Clinical Research Exome is the result of a multi-stage effort to first define and curate disease- associated targets and then, in partnership with Agilent, create an exome that delivers 10% more reads at 20x in these specific regions from OMIM, HGMD and ClinVar, while providing comprehensive coverage of the rest of the exome with only 4Gb of sequencing.
From the leader in target enrichment, SureSelect Clinical Research Exome, developed in collaboration with researchers from Emory University and The Children's Hospital of Philadelphia, enables comprehensive coverage of the exome, 80% of Human All Exon V5 targets at 20x, and even deeper coverage of disease-associated targets as defined by databases such as the Online Mendelian Inheritance in Man (OMIM), Human Genome Mutation Database (HGMD), and NCBI's ClinVar, 10% more of targeted bases covered at 20x with only 4Gb of sequencing (Figure 1), and even more with increased sequencing.
The SureSelect Clinical Research Exome utilizes the high-performing Human All Exon V5 as its core design with boosted coverage in disease-associated regions, enabling deep coverage of more targets compared to competitor's design when sequenced at equivalent average coverage (Figure 2A), facilitating variant calling within these targets while maintaining the balanced and comprehensive coverage of the exome (Figure 2B). This design consists of targets included in databases such as the Online Mendelian Inheritance in Man (OMIM), the Human Genome Mutation Database (HGMD) and NCBI's ClinVar. Ancestry- and identity- informative marker panels that enable better sample tracking and provide increased confidence in data reporting have also been included. In addition, the Clinical Research Exome enables customization through the addition of up to 6Mb of content using SureDesign, a simple and easy-to-use online tool for custom library design.
The SureSelect Clinical Research Exome is a highly optimized design that provides comprehensive analysis of protein-coding regions, enabling confident variant calling with the least amount of sequencing, only 4Gb for exomes. When paired with highly stringent SureSelect workflows that enable greatly reduced hybridization times, as little as 90 minutes, this exome provides 2.5x greater throughput (Figure 3) compared to competing products with a similar capture size. Data generated can easily be analyzed using SureCall, Agilent's analysis software, that generates variant calls from raw data in hours enabling greatly reduced time to results.
貨號 | 產品 | 數量 | |
---|---|---|---|
5190-7338 | SureSelectXT Clinical Research Exome | 16 rxns | |
5190-7339 | SureSelectXT Clinical Research Exome | 96 rxns | |
5190-7344 | SureSelectXT Clinical Research Exome | 96 rxns Auto | |
5190-7345 | SureSelectXT2 Clinical Research Exome | 16 rxns | |
5190-7346 | SureSelectXT2 Clinical Research Exome | 96 rxns | |
5190-7347 | SureSelectXT2 Clinical Research Exome | 96 rxns Auto |